226 related articles for article (PubMed ID: 15603248)
1. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
Sbarbaro JA
Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248
[No Abstract] [Full Text] [Related]
2. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
Brixner DI
Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
[No Abstract] [Full Text] [Related]
3. PROTEKT years 1-3 (1999-2002): study design and methodology.
Harding I; Felmingham D
J Chemother; 2004 Dec; 16 Suppl 6():9-18. PubMed ID: 15690682
[No Abstract] [Full Text] [Related]
4. Cethromycin: a promising new ketolide antibiotic for respiratory infections.
Rafie S; MacDougall C; James CL
Pharmacotherapy; 2010 Mar; 30(3):290-303. PubMed ID: 20180612
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
6. Short-duration therapy for respiratory tract infections.
Goff DA
Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial drug use and resistance among respiratory pathogens in the community.
Low DE
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S206-13. PubMed ID: 11524720
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
Doern GV
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
[TBL] [Abstract][Full Text] [Related]
9. Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in a primary care setting.
Clark JP; Langston E
Mayo Clin Proc; 2003 Sep; 78(9):1113-24. PubMed ID: 12962166
[TBL] [Abstract][Full Text] [Related]
10. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
Carter PL
Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
12. Prulifloxacin: a new antibacterial fluoroquinolone.
Prats G; Rossi V; Salvatori E; Mirelis B
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):27-41. PubMed ID: 16441207
[TBL] [Abstract][Full Text] [Related]
13. The continuing challenge of lower respiratory tract infections.
Moellering RC
Clin Infect Dis; 2004 May; 38 Suppl 4():S319-21. PubMed ID: 15127364
[No Abstract] [Full Text] [Related]
14. Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections.
Nord CE; Farrell DJ; Leclercq R
Microb Drug Resist; 2004; 10(3):255-63. PubMed ID: 15383171
[TBL] [Abstract][Full Text] [Related]
15. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
Nicolau DP
Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247
[No Abstract] [Full Text] [Related]
16. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
17. Community-acquired bacterial respiratory tract infections.
Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
[No Abstract] [Full Text] [Related]
18. Telithromycin--a ketolide antibiotic for the treatment of outpatients with community-acquired respiratory tract infections.
Counts M
Clin Nurse Spec; 2005; 19(3):121-3. PubMed ID: 15897765
[No Abstract] [Full Text] [Related]
19. Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection.
Adeleye IA; Uwagboe UC
West Indian Med J; 2003 Dec; 52(4):325-6. PubMed ID: 15040073
[No Abstract] [Full Text] [Related]
20. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
